TWC
IRD

TD Waterhouse Canada’s Opus Genetics IRD Stock Holding History

TD Waterhouse Canada’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
+3,000
New +$14K ﹤0.01% 1772
2023
Q4 		– Sell
-40
Closed -$145 – 1810
2023
Q3 		$145 Buy
40
+20
+100% +$80 ﹤0.01% 1651
2023
Q2 		$87 Buy
+20
New +$95 ﹤0.01% 1704

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

TD Waterhouse Canada's IRD Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Opus Genetics (IRD) in Q2 2026: 3,000 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #1772 among its holdings. This is a return to the name: TD Waterhouse Canada previously reported a position in IRD as recently as Q3 2023.

TD Waterhouse Canada first reported a position in IRD in Q2 2023 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • TD Waterhouse Canada held 3,000 shares of Opus Genetics worth $12.5K as of Q2 2026.
  • Opus Genetics was a new TD Waterhouse Canada position in Q2 2026.
  • Opus Genetics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1772 holding.
  • TD Waterhouse Canada first reported a position in Opus Genetics in Q2 2023 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.